BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1584139)

  • 1. Tissue inhomogeneity correction for brachytherapy sources in a heterogeneous phantom with cylindrical symmetry.
    Meigooni AS; Nath R
    Med Phys; 1992; 19(2):401-7. PubMed ID: 1584139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Monte Carlo dose calculations near 125I sources in the presence of bounded heterogeneities.
    Das RK; Keleti D; Zhu Y; Kirov AS; Meigooni AS; Williamson JF
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):843-53. PubMed ID: 9240654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of radial dose functions for 103Pd, 125I, 145Sm, 241Am, 169Yb, 192Ir, and 137Cs brachytherapy sources.
    Meigooni AS; Nath R
    Int J Radiat Oncol Biol Phys; 1992; 22(5):1125-30. PubMed ID: 1555964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of radiation dosimetry in water and in solid phantom materials for I-125 and Pd-103 brachytherapy sources: EGS4 Monte Carlo study.
    Luxton G
    Med Phys; 1994 May; 21(5):631-41. PubMed ID: 7935197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
    Melhus CS; Rivard MJ
    Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo calculations and experimental measurements of dosimetric parameters of the IRA-103Pd brachytherapy source.
    Sadeghi M; Raisali G; Hosseini SH; Shavar A
    Med Phys; 2008 Apr; 35(4):1288-94. PubMed ID: 18491522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
    Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
    Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric study of a new polymer encapsulated palladium-103 seed.
    Bernard S; Vynckier S
    Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a phantom to validate high-dose-rate brachytherapy treatment planning systems with heterogeneous algorithms.
    Moura ES; Micka JA; Hammer CG; Culberson WS; DeWerd LA; Rostelato ME; Zeituni CA
    Med Phys; 2015 Apr; 42(4):1566-74. PubMed ID: 25832047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of solid phantoms with water for dosimetry of 125I brachytherapy sources.
    Meigooni AS; Meli JA; Nath R
    Med Phys; 1988; 15(5):695-701. PubMed ID: 3185404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources.
    Nath R; Meigooni AS; Muench P; Melillo A
    Med Phys; 1993; 20(5):1465-73. PubMed ID: 8289730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
    Asadi S; Vaez-Zadeh M; Vahidian M; Marghchouei M; Masoudi SF
    J Appl Clin Med Phys; 2016 May; 17(3):90-99. PubMed ID: 27167265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radial dose functions for 103Pd, 125I, 169Yb and 192Ir brachytherapy sources: an EGS4 Monte Carlo study.
    Mainegra E; Capote R; López E
    Phys Med Biol; 2000 Mar; 45(3):703-17. PubMed ID: 10730965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Simulation of dose distribution in bone medium of
    Ye KQ; Huang MW; Li JL; Tang JT; Zhang JG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):131-135. PubMed ID: 29483735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetry for 125I seed (model 6711) in eye plaques.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
    Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
    Chan GH; Prestwich WV
    Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
    Bannon EA; Yang Y; Rivard MJ
    Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.